RainCastle Announces Four New Clients, Marking a Major Step in its Commitment to Diversification
Newton, MA – April 30, 2002
RainCastle Communications, a design strategy company providing insightful brand strategies through integrated web and print design, today announced the addition of four new clients: ABIOMED, Northland Investment Corporation, Repligen Corporation and Thermogenic Imaging. The combined client wins affirm RainCastle's commitment to pursuing increasingly complex branding engagements with organizations that are leaders in a range of industries.
"We are thrilled to begin work with these clients, all of whom are innovators in their respective fields," said Paul Regensburg, RainCastle's president and creative director. "We are also pleased with the strides we have made in diversifying our client base, especially in biotech, pharma and medical devices. While it makes good economic sense, developing competency in a variety of target sectors has also been a welcome challenge for our entire staff."
- ABIOMED of Danvers, Mass. is a leader in the development of technologies to assist or replace the human heart. The AbioCorT Implantable Replacement Heart is being implanted in patients as part of an initial clinical trial, and the BVS® 5000 Bi-ventricular Support System is now the most widely used advanced cardiac assist system. RainCastle will be developing both a print and online version of ABIOMED's corporate Annual Report.
- Northland Investment Corp is a real estate operating company located in Newton, Mass. RainCastle has been tapped to create a branding campaign in support of a major development project in Hartford, CT. Project elements include brand strategy, logo and tagline, collateral materials, and project microsite.
- Repligen Corporation of Needham, Mass. is a biopharmaceutical company engaged in the development of new drugs for debilitating pediatric disorders including autism, immune and metabolic disorders. Repligen has contracted RainCastle to design its fiscal 2002 Annual Report, as well as to develop brand strategy and launch support materials for its recently approved drug, SecreFloT.
- Thermogenic Imaging of Billerica, Mass. commercializes the novel application of Thermal Signature Analysis (TSA) to drug discovery and development. RainCastle will be creating a robust Web site and collateral materials to help support business development and partnership efforts.
